Clothing for protection against infectious agents — Medical face masks — Test method for resistance against penetration by synthetic blood (fixed volume, horizontally projected)

ISO 22609:2004 describes a laboratory test method for measuring the resistance of medical face masks to penetration by a splash of synthetic blood. ISO 22609:2004 primarily addresses the performance of materials or certain material constructions used in medical face masks. The test method does not address the performance of the medical face mask's design, construction, interfaces or other factors which may affect the overall protection offered by the medical face mask and its operation (such as filtration efficiency and pressure drop). ISO 22609:2004 does not evaluate the performance of medical face masks as a protection against contamination via airborne exposure pathways or in the prevention of the penetration of aerosolized body fluids deposited on the medical face mask.

Vêtements de protection contre les agents infectieux — Masques faciaux médicaux — Méthode d'essai de la résistance à la pénétration par un sang synthétique (volume fixe, projection horizontale)

General Information

Status
Published
Publication Date
02-Dec-2004
Current Stage
9093 - International Standard confirmed
Completion Date
10-Jun-2020
Ref Project

Relations

Buy Standard

Standard
ISO 22609:2004 - Clothing for protection against infectious agents -- Medical face masks -- Test method for resistance against penetration by synthetic blood (fixed volume, horizontally projected)
English language
17 pages
sale 15% off
Preview
sale 15% off
Preview

Standards Content (Sample)

INTERNATIONAL ISO
STANDARD 22609
First edition
2004-12-01

Clothing for protection against infectious
agents — Medical face masks — Test
method for resistance against
penetration by synthetic blood (fixed
volume, horizontally projected)
Vêtements de protection contre les agents infectieux — Masques
faciaux médicaux — Méthode d'essai de la résistance à la pénétration
par un sang synthétique (volume fixe, projection horizontale)




Reference number
ISO 22609:2004(E)
©
ISO 2004

---------------------- Page: 1 ----------------------
ISO 22609:2004(E)
PDF disclaimer
This PDF file may contain embedded typefaces. In accordance with Adobe's licensing policy, this file may be printed or viewed but
shall not be edited unless the typefaces which are embedded are licensed to and installed on the computer performing the editing. In
downloading this file, parties accept therein the responsibility of not infringing Adobe's licensing policy. The ISO Central Secretariat
accepts no liability in this area.
Adobe is a trademark of Adobe Systems Incorporated.
Details of the software products used to create this PDF file can be found in the General Info relative to the file; the PDF-creation
parameters were optimized for printing. Every care has been taken to ensure that the file is suitable for use by ISO member bodies. In
the unlikely event that a problem relating to it is found, please inform the Central Secretariat at the address given below.


©  ISO 2004
All rights reserved. Unless otherwise specified, no part of this publication may be reproduced or utilized in any form or by any means,
electronic or mechanical, including photocopying and microfilm, without permission in writing from either ISO at the address below or
ISO's member body in the country of the requester.
ISO copyright office
Case postale 56 • CH-1211 Geneva 20
Tel. + 41 22 749 01 11
Fax + 41 22 749 09 47
E-mail copyright@iso.org
Web www.iso.org
Published in Switzerland

ii © ISO 2004 – All rights reserved

---------------------- Page: 2 ----------------------
ISO 22609:2004(E)
Contents Page
Foreword. iv
Introduction . v
1 Scope. 1
2 Normative references . 1
3 Terms and definitions. 1
4 Principle . 2
5 Apparatus and materials . 3
5.1 Equipment. 3
5.2 Reagents . 4
6 Specimens . 4
7 Procedure . 4
7.1 Preparation and cleaning of test apparatus. 4
7.2 Test procedure . 5
7.3 Alternative test set-up using a targeting plate. 6
8 Report. 7
Annex A (informative) Parts list for test apparatus. 11
Annex B (normative) Preparation of synthetic blood . 12
Annex C (informative) Derivation of equations for stream velocity and time of delivery. 13
Bibliography . 17

© ISO 2004 – All rights reserved iii

---------------------- Page: 3 ----------------------
ISO 22609:2004(E)
Foreword
ISO (the International Organization for Standardization) is a worldwide federation of national standards bodies
(ISO member bodies). The work of preparing International Standards is normally carried out through ISO
technical committees. Each member body interested in a subject for which a technical committee has been
established has the right to be represented on that committee. International organizations, governmental and
non-governmental, in liaison with ISO, also take part in the work. ISO collaborates closely with the
International Electrotechnical Commission (IEC) on all matters of electrotechnical standardization.
International Standards are drafted in accordance with the rules given in the ISO/IEC Directives, Part 2.
The main task of technical committees is to prepare International Standards. Draft International Standards
adopted by the technical committees are circulated to the member bodies for voting. Publication as an
International Standard requires approval by at least 75 % of the member bodies casting a vote.
Attention is drawn to the possibility that some of the elements of this document may be the subject of patent
rights. ISO shall not be held responsible for identifying any or all such patent rights.
ISO 22609 was prepared by Technical Committee ISO/TC 94, Personal safety — Protective clothing and
[4]
equipment, Subcommittee SC 13, Protective clothing. It is based on ASTM F1862-00a .

iv © ISO 2004 – All rights reserved

---------------------- Page: 4 ----------------------
ISO 22609:2004(E)
Introduction
Workers, primarily those in the health care profession, involved in treating and caring for individuals injured or sick,
can be exposed to biological liquids capable of transmitting disease. These diseases, which may be caused by a
variety of microorganisms, can pose significant risks to life and health. This is especially true of blood-borne
viruses that cause hepatitis [Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV)] and acquired immune
deficiency syndrome (AIDS) [Human Immunodeficiency Virus (HIV)]. Since engineering controls cannot eliminate
all possible exposures, attention is placed on reducing the potential of direct skin contact through the use of
protective clothing that resists penetration. This test method was developed for ranking the synthetic blood
penetration resistance performance of medical face masks in a manner representing actual use as might occur
when the face mask is contacted by a high velocity stream of blood from a punctured wound.
The test method is intended to evaluate the protection of the health care provider’s face from exposure to blood
and body fluids. It is used to evaluate the resistance of medical face masks to penetration by synthetic blood
under high-velocity liquid contact with the medical face mask surface of a fixed volume over a relatively short
period of time (0 s to 2,5 s). Medical face mask “pass/fail” determinations are based on visual detection of
synthetic blood penetration.
NOTE 1 Medical face masks are intended to resist liquid penetration from the splatter or splashing of blood, body fluids,
and other potentially infectious materials. Many factors can affect the wetting and penetration characteristics of body fluids,
such as: surface tension; viscosity; and polarity of the fluid, as well as the structure and relative hydrophilicity or
hydrophobicity of the materials. The surface tension range for blood and body fluids (excluding saliva) is approximately
[1]
0,042 N/m to 0,060 N/m . To help simulate the wetting characteristics of blood and body fluids, the surface tension of the
synthetic blood is adjusted to approximate the lower end of this surface tension range. The resulting surface tension of the
synthetic blood is (0,042 ± 0,002) N/m.
NOTE 2 During a medical procedure, a blood vessel can be punctured resulting in a high-velocity stream of blood
impacting a protective medical face mask. The impact velocity depends on several factors, the most important being the
blood pressure of the patient. A second factor is the distance from the puncture. The velocity of larger punctures drops
because the pressure in the blood vessel drops quickly. Because only small punctures cause high-velocity streams, large
punctures were not used to model the range of blood-splatter velocities considered in this test. Furthermore, this test
method is based on the assumption that the medical face mask will be in close proximity to the puncture area. This test
method is therefore based on the impact velocity of a stream of fluid that corresponds to the target blood pressure.
NOTE 3 The mean human blood pressure generally varies over a range of about 10,6 kPa to 16,0 kPa (80 mm Hg to
[2]
120 mm Hg) . In this test method, medical face masks are tested at stream velocities corresponding to 10,6 kPa,
16,0 kPa, and 21,3 kPa (80 mm Hg, 120 mm Hg, and 160 mm Hg, respectively). This test method permits the use of other
non-standard test pressures, stream velocities, fluid volumes, and specimen orientations for evaluating medical face mask
penetration resistance consistent with specific applications.
This International Standard does not apply to all forms or conditions of blood-borne pathogen exposure. Users of
the test method should review modes for face exposure and assess the appropriateness of this test method for
their specific application.
This International Standard primarily addresses the performance of materials or certain material constructions
used in medical face masks. This test method does not address the performance of the medical face mask's
design, construction, interfaces or other factors which may affect the overall protection offered by the medical face
mask and its operation (such as filtration efficiency and pressure drop).
This test method does not address breathability of the medical face mask materials or any other properties
affecting the ease of breathing through the medical face mask. This test method evaluates medical face
masks as an item of protective clothing. This test method does not evaluate the performance of medical face
masks as protection against contamination via airborne exposure pathways or in the prevention of the
penetration of aerosolized body fluids deposited on the medical face mask.
© ISO 2004 – All rights reserved v

---------------------- Page: 5 ----------------------
ISO 22609:2004(E)
NOTE 4 Users of this test method should realize that certain tradeoffs exist between improved resistance of medical
face masks to penetration by synthetic blood and in pressure drop across mask materials which is an indicator of the
breathability of the face mask. In general, increasing synthetic blood penetration resistance for medical face masks results
in increasing pressure drop or reduced breathability for medical face masks of the same design and fit of the individual
wearer.
NOTE 5 This test method evaluates medical face masks as an item of protective clothing and does not evaluate
medical face masks as respirators. If respiratory protection for the wearer is needed, an approved respirator should be
used. This test method can be used to evaluate the resistance of a respirator to penetration by synthetic blood, if
warranted.

vi © ISO 2004 – All rights reserved

---------------------- Page: 6 ----------------------
INTERNATIONAL STANDARD ISO 22609:2004(E)

Clothing for protection against infectious agents — Medical
face masks — Test method for resistance against penetration
by synthetic blood (fixed volume, horizontally projected)
1 Scope
This International Standard describes a laboratory test method for measuring the resistance of medical face
masks to penetration by a splash of synthetic blood.
This International Standard primarily addresses the performance of materials or certain material constructions
used in medical face masks. This test method does not address the performance of the medical face mask's
design, construction, interfaces or other factors which may affect the overall protection offered by the medical face
mask and its operation (such as filtration efficiency and pressure drop).
This test method does not evaluate the performance of medical face masks as a protection against
contamination via airborne exposure pathways or in the prevention of the penetration of aerosolized body
fluids deposited on the medical face mask.
2 Normative references
The following referenced documents are indispensable for the application of this document. For dated
references, only the edition cited applies. For undated references, the latest edition of the referenced
document (including any amendments) applies.
ISO 304, Surface active agents — Determination of surface tension by drawing up liquid films
ISO 2859-1, Sampling procedures for inspection by attributes — Part 1: Sampling schemes indexed by
acceptance quality limit (AQL) for lot-by-lot inspection
3 Terms and definitions
For the purposes of this document, the following terms and definitions apply.
3.1
aerosolized body fluids
body fluids which have been dispersed into air as very small liquid droplets
3.2
airborne exposure pathways
inhalation routes of exposure to the medical face mask wearer
NOTE Inhalation routes of exposure do not include streams of blood or body fluid that may be expelled from a wound.
3.3
blood-borne pathogen
any infectious secreted or excreted bacterium, virus, or other disease-inducing microbe carried in blood or
other body fluids
© ISO 2004 – All rights reserved 1

---------------------- Page: 7 ----------------------
ISO 22609:2004(E)
3.4
body fluid
any liquid produced (secreted or excreted) by the body
NOTE For the purpose of this International Standard, body fluids include those liquids potentially infected with blood-
borne pathogens, including, but not limited to, blood, semen, vaginal secretions, cerebrospinal fluid, synovial fluid and
peritoneal fluid, amniotic fluid, saliva in dental procedures, and any body fluid that is visibly contaminated with blood, and
all body fluids in situations where it is difficult or impossible to differentiate between body fluids.
3.5
body-fluid simulant
liquid which is used to act as a model for human body fluids
3.6
medical face mask
item of protective clothing designed to protect portions of the wearer's face, including at least the mucous
membrane areas of the wearer's nose and mouth, from contact with blood and other body fluids during
medical procedures
3.7
penetration
flow of particles or liquids through closures, porous materials, seams and holes or other imperfections in a
protective clothing material
NOTE In this International Standard, the penetration liquid is synthetic blood.
3.8
protective clothing
any material or combination of materials used in an item of clothing for the purpose of isolating parts of the
body from contact with a potential hazard
NOTE For the purpose of this International Standard, the potential hazard of contact with blood or other body fluids is
simulated.
3.9
synthetic blood
mixture of amaranth dye, surfactant, thickening agent, inorganic salts and distilled water having a surface
tension representative of blood and some other body fluids
NOTE The synthetic blood in this test method does not simulate all of the characteristics of blood or body fluids. For
example, this synthetic blood does not simulate polarity (wetting characteristics), coagulation, or content of cell matter.
4 Principle
A specimen medical face mask is supported on an apparatus. A volume of synthetic blood is sprayed
horizontally at the specimen mask to simulate the scenario of a mask being splashed by a punctured blood
vessel. The volume of fluid, distance to impact, orifice size and fluid velocity are defined in this method and
intended to be consistent with this health care scenario.
Any evidence of synthetic blood penetration on the side of the medical face mask contacting the wearer’s face
constitutes failure. Results are reported as “pass/fail”.
Specimen medical face masks are evaluated at a total of three different velocities corresponding to human blood
pressures of 10,6 kPa, 16,0 kPa, and 21,3 kPa. Test results are reported at each velocity and the medical face
mask is rated at the highest corresponding blood pressure for which medical face mask specimens demonstrate
an acceptable quality limit of 4,0.
2 © ISO 2004 – All rights reserved

---------------------- Page: 8 ----------------------
ISO 22609:2004(E)
NOTE This test method differs from ISO 16603 by dispensing a stream of 2 ml of synthetic blood against the target
area of a complete medical mask specimen whereas ISO 16603 involves the continuous contact of a specimen of
protective clothing with synthetic blood over the period of an hour. The exposure time of 1 min in ISO 16603 is at a
hydrostatic pressure of 13,8 kPa. ISO 16603 is used for preliminary evaluation of protective clothing penetration resistance
to synthetic blood in conjunction with ISO 16604, which uses a microbiological challenge. Both procedures are intended
for assessment of protective clothing that has the potential to contact blood or other body fluids for extended periods of
time, and under pressure.
5 Apparatus and materials
5.1 Equipment
5.1.1 Test apparatus, capable of affixing the specimen medical face mask and dispensing synthetic blood
at the target area of the specimen and consisting of a specimen-holding fixture, a fluid reservoir, a pneumatic-
controlled valve and valve controller to dispense a specified volume of synthetic blood through a small-
diameter canula in a controlled amount of time, and a valve control switch as shown in Figure 1.
Dimensions for the test apparatus are provided in Figure 2. A parts list for the test apparatus is given in
Annex A. Alternative designs are permitted as long as the same operational characteristics are achieved.
Dimensions for the specimen-holding fixture are provided in Figure 3. It should be convex and apply only
enough pressure to gently stretch the specimen while holding it firmly in place 300 mm from the tip of the
canula on the valve. Metal clips or an elastic cuff may be used to hold the specimen against the fixture
provided they remain away from the target area and do not damage the specimen.
NOTE The specimen-holding fixture illustrated in Figures 2 and 3 consists of a platform on which is mounted an
open-ended transparent plastic box. The platform is fitted with a vertical ring clamp used to hold the pneumatic valve. The
front of the box has a hole cut in it to fit the convex mounting fixture on the outer door where the specimens are positioned.
The outer door is closed with the specimen in position and the specimen is held between the wall of the box and the door.
The door is held closed by magnetic strips along the top of the box and the door. A hole is cut through the centre of the
convex specimen-mounting fixture and the door to allow the test operator to visually note if any fluid penetrates to the
inside layer of the specimen medical face mask.
5.1.2 Air-pressure source, capable of providing air at a gage pressure of (700 ± 25) kPa.
5.1.3 Graduated cylinder, calibrated and graduated to measure liquid with a precision of 0,1 ml.
NOTE A 10 ml graduated cylinder with an expanded lip has been found to be a convenient size.
5.1.4 Balance, calibrated and with a precision of at least 0,01 g.
5.1.5 Temperature/humidity recorder, capable of monitoring the ambient temperature (to ± 0,5 °C) and
humidity (to ± 1 %) during testing.
5.1.6 Controlled temperature and humidity chamber or space, capable of maintaining the specified
temperature and humidity conditions for preconditioning of specimens.
5.1.7 Targeting plate, a recommended addition to the test apparatus, consisting of a plate with a 0,5 cm
hole as shown in Figures 3 and 4, which can be positioned so that the hole is centred approximately 1 cm in
front of the specimen mask, between the mask and the canula, such that the fluid stream passing through the
hole impacts the centre of the specimen mask. The targeting plate blocks the high pressure leading edge of
the stream and allows only the steady-state stream to impact the mask, thus increasing the accuracy and
repeatability of the velocity of the stream which impacts the specimen masks. Subclause 7.3 should be used
for setting the test pressure when using the targeting plate.
The splatter of fluid hitting the targeting plate can be contained by using a disposable plastic cup with the
appropriately sized hole punched in the bottom as the targeting plate. The cup is mounted horizontally with the
opening facing the nozzle by any convenient method. The cup in Figure 4 is supported by a sheet of lexan.
The cup fits in a hole in the lexan that is the diameter of the base of the cup. The lexan is set in a notched
© ISO 2004 – All rights reserved 3

---------------------- Page: 9 ----------------------
ISO 22609:2004(E)
stand to hold it upright. A second cup placed below the lip of the targeting cup can be used to collect the run-
off.
5.2 Reagents
5.2.1 Synthetic blood, prepared as described in Annex B.
NOTE Because the synthetic blood readily stains clothing, wear a laboratory coat or similar cover during testing.
Wear a face shield or use a fixed shield if standing behind the test specimen for observing its performance.
5.2.2 Isopropanol, of laboratory grade, for cleaning the canula and surfaces contacted by the synthetic
blood.
6 Specimens
Use complete medical face masks as the test specimen.
If in the design of a medical face mask, different materials or thicknesses of material are specified at different
locations, test each area of the specimen separately. If in the design of a medical face mask, seams are claimed
to offer the same protection as the base materials, test these areas of the face mask separately.
Test a sufficient number of specimens taken at random for each type, design, or lot of medical face masks to
achieve an acceptable quality limit (AQL) of 4,0 %, as defined in ISO 2859-1, at each selected test pressure.
NOTE A single sampling plan providing an AQL of 4,0 % requires 32 specimens.
If warranted, use other pre-treatment options, such as pre-wetting, to assess possible mechanisms which degrade
the effectiveness of medical face masks.
Testing without including degradation by physical, chemical, and thermal stresses that could negatively impact
the performance of the protective barrier, might lead to a false sense of security. Consider tests that assess
the impact of storage conditions and shelf life for disposable products, and the effects of laundering and
sterilization for reusable products. The integrity of the protective clothing can also be compromised during use
[3]
by such effects as flexing and abrasion . It is possible that pre-wetting by contaminants such as alcohol and
perspiration also compromises the integrity of the protective clothing. If these conditions are of concern,
evaluate the performance of protective clothing for synthetic blood penetration following an appropriate pre-
treatment technique representative of the expected conditions of use.
Condition each specimen for a minimum of 4 h by exposure to a temperature of (21 ± 5) °C and a relative
humidity of (85 ± 5) % using a controlled temperature and humidity chamber or space.
This test method involves the preconditioning of specimen medical face masks in a relatively high humidity
environment (85 ± 5) % relative humidity at (21 ± 5) °C to simulate the conditions of use when the wearer
creates high-humidity conditions by breathing through the mask. This preconditioning does not account for
saturation of the interior medical face mask layer. However, additional pre-treatment techniques may be used
in conjunction with this test method. Professional health care providers recommend that medical face masks
be replaced when saturation occurs from breathing or from contact with other liquids.
7 Procedure
7.1 Preparation and cleaning of test apparatus
NOTE 1 An alternative test set-up procedure is provided in 7.3 that utilizes a targeting plate to ensure a more accurate
and uniform velocity of fluid to the specimen mask.
Prepare and clean the test apparatus using the following steps.
4 © ISO 2004 – All rights reserved

---------------------- Page: 10 ----------------------
ISO 22609:2004(E)
a) Install a clean 12,7 mm long canula with an inside diameter of 0,84 mm on the front of the pneumatic-
controlled valve.
b) Fill the reservoir with new synthetic blood (approximately 1 l).
c) Set the valve time corresponding to the blood pressure being assessed in accordance with Table 1. If
non-standard pressures, fluid volumes (2 ml) or canula sizes (0,084 cm ID) are employed, the valve time
should be calculated using Equations (C.4) and (C.7) in Annex C.
Table 1 — Valve times for standard test pressures
Pressure Velocity Valve time for standard
 apparatus and fluid
(kPa) (cm/s) (s)
10,6 450 0,80
16,0 550 0,66
21,3 635 0,57

NOTE 2 For the purposes of this test method, as a minimum three different sets of specimens at stream velocities
corresponding to blood pressures of 10,6 kPa, 16,0 kPa, and 21,3 kPa are evaluated.
d) Adjust the reservoir pressure as needed to achieve a flow of 2 ml for the selected valve time.
e) Verify the amount of synthetic blood delivered to be 2 ml by conducting trials into a graduated cylinder.
Alternatively, the volume of synthetic blood can be measured by determining the mass using a balance.
For the standard fluid, with a specific gravity of 1,005, the 2 ml of fluid would weigh (2,010 ± 0,040) g.
f) After every 16 specimens, ensure that the text apparatus is delivering 2 ml of synthetic blood by following
the method calibration steps as directed in 7.1 d) and 7.1 e).
g) If the canula is left unused for 1 h or more after synthetic blood has passed through it during testing,
replace it with a clean canula and clean the used canula.
h) Clean the canula by immersing in isopropanol for 24 h and rinsing with distilled water.
i) Following testing, clean the system lines and the reservoir with distilled water. Do not use isopropanol or
other solvents on the valve or system lines as the valve may be damaged.
7.2 Test procedure
Use the following steps to evaluate medical face masks.
a) Conduct all testing in an environment having a temperature of (21 ± 5) °C and a relative humidity of
(85 ± 10) %.
b) Place a small droplet (approximately 0,1 ml) of the synthetic blood on the normal inside surface of an
extra medical face mask. The droplet shall be easily visible to ensure that any droplet that penetrates the
material will be seen. If not, use talcum powder on the normal inside surface of the medical face mask to
enhance droplet visibility.
c) Remove a specimen from the conditioning chamber. Mount the specimen on the specimen-holding fixture
and position the specimen for impact of the synthetic blood to occur in the target area.
If the face mask contains pleats, spread the pleats out when mounting the face mask onto the test fixture
to present a single layer of material as the target area. Use the centre of the specimen as the target area.
© ISO 2004 – All rights reserved 5

---------------------- Page: 11 ----------------------
ISO 22609:2004(E)
Position the end of the pneumatic-controlled valve at a distance of (300 ± 10) mm from the target area
from the specimen.
d) Squirt the synthetic blood onto the specimen medical face mask. Ensure that the synthetic blood hits the
target area of the medical face mask. Conduct the test within 60 s after removal from conditioning
chamber.
e) Inspect the viewing side of the specimen for synthetic blood (10 ± 1) s after squirting the synthetic blood
against the target area. Note whether any synthetic blood or other evidence of wetness, or both, appears
on the viewing side of the specimen using suitable lighting.
Use a cotton absorbent swab or similar item to lightly daub the target area if there is any doubt regarding the
visible penetration of the synthetic blood.
f) Test the remaining specimens.
7.3 Alternative test set-up using a targeting plate
The following procedure improves the accuracy of the velocity of the stream hitting the target mask. Once the
valve opens, the pressure of the fluid at the tip drops as frictional losses build as the fluid flows through the
tubing, valve and canula. The net result is that the pressure of the initial portion of the stream can be two to
three times the target pressure. This procedure blocks this h
...

Questions, Comments and Discussion

Ask us and Technical Secretary will try to provide an answer. You can facilitate discussion about the standard in here.